LEVETIRACETAM is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Levetiracetam.
Product ID | 0409-1886_03374e0c-71b6-459e-be3f-acf24456d71b |
NDC | 0409-1886 |
Product Type | Human Prescription Drug |
Proprietary Name | LEVETIRACETAM |
Generic Name | Levetiracetam |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2012-11-02 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202869 |
Labeler Name | Hospira, Inc. |
Substance Name | LEVETIRACETAM |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202869 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-06-13 |
Marketing Category | ANDA |
Application Number | ANDA202869 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-03-01 |
Marketing Category | ANDA |
Application Number | ANDA202869 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-03-01 |
Marketing Category | ANDA |
Application Number | ANDA202869 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-11-02 |
Marketing End Date | 2012-08-08 |
Marketing Category | ANDA |
Application Number | ANDA202869 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2012-11-02 |
Ingredient | Strength |
---|---|
LEVETIRACETAM | 100 mg/mL |
SPL SET ID: | ed1b74a8-2a9b-4315-b051-673c7941cb13 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |